Journal of the International AIDS Society

Article	Citations
When and how to intervene to improve the health of children born HIV‐free	79
“If they had a place to live, they would be taking medication”: a qualitative study identifying strategies for engaging street‐connected young people in the HIV prevention‐care continuum in Ken	67
Understanding adaptive responses in PrEP service delivery in Belgian HIV clinics: a multiple case study using an implementation science framework	53
HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual	51
Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review	44
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study	44
Systematic review and meta‐analysis of retention and disengagement after initiation on antiretroviral therapy in low‐ and middle‐income countries after the introduction of Universal Test and Treat pol	41
Population‐level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)	40
Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre‐exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open‐label pharm	39
Sustaining the HIV/AIDS response: PEPFAR's vision	39
Towards More Accessible and More Inclusive PrEP to Break the Cycle of HIV in France	38
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limit	36
Counselling behavioural interventions for HIV, STI and viral hepatitis among key populations: a systematic review of effectiveness, values and preferences, and cost studies	36
	35
	35
Effects of Stop‐Work orders on HIV testing, treatment and programmes for prevention of vertical transmission in four sub‐Saharan African countries	35
Issue Information	34
Effectiveness of HIV self‐testing when offered within assisted partner services in Western Kenya (APS‐HIVST Study): a cluster randomized controlled trial	34
Issue Information	33
Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster‐randomized	32
Patterns of person‐centred communications in public HIV clinics: a latent class analysis using the Roter interaction analysis system	32
Differentiating the incidence and burden of HIV by age among women who sell sex: a systematic review and meta‐analysis	30
Contents	30
Experiences of oral pre‐exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study	29
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers	29

Using community conversations to integrate violence screening and referrals into HIV care for young women living with HIV in Lusaka, Zambia	29
A cross‐sectional assessment of injection of “salts” and HIV transmission‐related behaviours among a cohort of people who inject drugs in Kyrgyzstan	28
Issue Information	28
Community‐led monitoring: a voice for key populations in Zimbabwe	27
Managers’ and providers’ perspectives on barriers and facilitators for the implementation of differentiated service delivery models for HIV treatment in Mozambique: a qualitative study	27
India's adaptation of HIV services to ensure continuity of service delivery during the COVID‐19 pandemic	27
Socio‐economic status and adherence to HIV preventive and therapeutic interventions: exploring the mediating role of food insecurity among men who have sex with men and transgender and non‐binary pers	26
A cross‐sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV‐1 in tenofovir disoproxil fumarate‐based pre‐exposure prophylaxis rollout program	26
Empowering at‐risk Thai adolescents and young adults: an observational study of “Stand By You” – a person‐centred online service model for HIV self‐screening, text‐based counselling and linkage to car	25
Navigating the Data Gaps of Ageing Among Women Living With HIV	25
Leveraging HIV self‐testing to achieve the UNAIDS 2025 targets in the South and Southeast Asia region	25
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis	25
The lavender purge	25
Ageing with HIV: a longitudinal study of markers of resilience in young adults with perinatal exposure to HIV, with or without perinatally acquired HIV	25
Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies	24
	24
Adaptation and psychometric evaluation of a scale to measure oral pre‐exposure prophylaxis‐related stigma among key and vulnerable populations in Kenya	23
Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community‐based sociometric network cohort in New Delhi, India	23
Feasibility and acceptability of peer‐delivered HIV and syphilis self‐test kits and assisted partner notification services for gay, bisexual and other men who have sex with men: a qualitative study in	22
	22
Implementation strategies to improve HIV care cascade outcomes in low‐ and middle‐income countries: a systematic review from 2014 to 2021	22
Healthcare provisions associated with multiple HIV‐related outcomes among adolescent girls and young women living with HIV in South Africa: a cross‐sectional study	22
ChemsexPH: The association between chemsex, HIV status and adherence to antiretroviral therapy among men who have sex with men in the Philippines	22
Contents	22
Using FRAME to characterize provider‐identified adaptations to a stepped care intervention for adolescents and youth living with HIV in Kenya: a mixed methods approach	21
Monitoring adherence to antiretroviral therapy among adolescents in Southern Uganda: comparing Wisepill to Self‐report in predicting viral suppression in a cluster‐randomized trial	21
Achieving equity for children and adolescents with perinatal HIV exposure: an urgent need for a paradigm shift	21
Age, sex—and what else? Rethinking priorities to close gaps in the HIV care cascade	21
	20
Sarcopenia in people living with HIV in Hong Kong: which definition correlates with health outcomes?	20
Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition	20
Issue Information	20
Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta‐analysis	20
Impart: findings from a prison‐based model of HIV assisted partner notification in Indonesia	19
Factors associated with mobile app‐based ordering of HIV self‐test kits among men who have sex with men in Atlanta, Detroit and New York City: an exploratory secondary analysis of a randomized control	19
AUTHOR INDEX	19
Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP	19
Client experiences with “Dynamic Choice Prevention,” a model for flexible patient‐centred HIV prevention delivery in rural Eastern Africa	19
Issue Information	19
	19
COVID‐19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa	19
Methodological issues in the designing and reporting of frequentist and Bayesian meta‐analysis to assess COVID‐19 outcomes among PLHIV with various comorbidities	19
Incident HIV acquisition among pregnant women in Botswana: findings from the Tsepamo birth outcomes surveillance study	18
Impact of the COVID‐19 pandemic on TB services at ART programmes in low‐ and middle‐income countries: a multi‐cohort survey	18
Providing differentiated service delivery to the ageing population of people living with HIV	18
Cost‐Effectiveness and Budget Impact Analysis of the Implementation of Differentiated Service Delivery Models for HIV Treatment in Mozambique: a Modelling Study	18
Clients in Uganda accessing preferred differentiated antiretroviral therapy models achieve higher viral suppression and are less likely to miss appointments: a cross‐sectional analysis	18
Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual	18
Preferences for TB treatment and support delivery models among people living with TB in Eastern Cape, South Africa: a discrete choice experiment	17
Improving PrEP access for adolescent girls and young women: a descriptive analysis of community‐based PrEP delivery in the DREAMS programme in Zambia	17

Lessons learned from community engagement regarding phylodynamic research with molecular HIV surveillance data	17
Feasibility and acceptability of persons on long‐acting cabotegravir for HIV prevention in the SEARCH Dynamic Choice HIV Prevention trial extension in rural Kenya and Uganda: a longitudinal cohort stu	17
The impact of prevention‐effective PrEP use on HIV incidence: a mathematical modelling study	17
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study	17
Integrating postal HIV testing into the HIV care cascade in Japan: a public health centre model	17
“It gives me the strength and courage to take care of myself”: a qualitative exploration of experiences with STI testing among women who initiated PrEP during pregnancy in Western Kenya	17
Caring for the whole person: transgender‐competent HIV pre‐exposure prophylaxis as part of integrated primary healthcare services in Vietnam	17
Costs and cost‐effectiveness of a collaborative data‐to‐care intervention for HIV treatment and care in the United States	16
Certification of lay providers to deliver key population‐led HIV services in Thailand's National Healthcare System: lessons learned	16
What can we learn from HIV, COVID‐19 and mpox stigma to guide stigma‐informed pandemic preparedness?	16
The role of internalised HIV stigma in disclosure of maternal HIV serostatus to children perinatally HIV‐exposed but uninfected: a prospective study in the United States	16
Finally, PrEP choices! But will clients ever have a choice?	16
Ethical HIV research with transgender and non‐binary communities in the United States	16
	15
Shaping and coordinating the implementation science agenda for injectable cabotegravir for PrEP: the role of the Biomedical Prevention Implementation Collaborative (BioPIC)	15
Assessing the HIV care continuum among transgender women during 11 years of follow‐up: results from the Netherlands’ ATHENA observational cohort	15
Cost‐effectiveness of hepatitis C virus test‐and‐treat and risk reduction strategies among men who have sex with men living with HIV in France	15
From Kigali to Rio: advancing an evidence‐based and equitable HIV response	15
Fostering citizen‐engaged HIV implementation science	15
Community contexts and knowledge: accountability, leadership and meaningful involvement of communities in Programme Science	15
	15
Setting up for success: the effectiveness of telling children about their HIV status	15
Evidence from high‐income countries on the effectiveness of psychosocial interventions to improve mental health, wellbeing and quality of life for adults living with HIV: a systematic review and meta‐	15
HIV knowledge and access to testing for people with and without disabilities in low‐ and middle‐income countries: evidence from 37 Multiple Indicator Cluster Surveys	14
Lessons from the field: understanding the use of a youth tailored U = U tool by peer educators in Lesotho with adolescents and youth living with HIV	14
Issue Information	14
A prospective cohort study of the SEARCH integrated HIV/hypertension community health worker‐led intervention in rural Kenya and Uganda	14
Impact of Tenofovir Alafenamide Sub‐Dermal Implant Insertion Site Scarring on Acceptability and HIV Prevention Preferences: A Prospective Cohort Study in Durban, South Africa	14
	14
Issue Information	14
Implementation research and the HIV response: Taking stock and charting the way forward	14
Improving access to integrated community‐based HIV, HCV and harm reduction services for people who inject drugs in Putao district, North Myanmar	14
Advanced disease programming brings much needed attention and improvements to inpatient paediatric HIV care in Mozambique	14
Implementation and resource needs for long‐acting PrEP in low‐ and middle‐income countries: a scoping review	14
HIV incidence and prevalence among adults in Mozambique: estimates from the Population‐based HIV Impact Assessment Survey (INSIDA 2021) and district‐level modelling	14
Issue Information	13
Health‐related needs reported by adolescents living with HIV and receiving antiretroviral therapy in sub‐Saharan Africa: a systematic literature review	13
	13
A thank you note to our peer reviewers (2024)	13
REPRIEVE final results: What does it mean for guidelines in low‐ and middle‐income countries?	13
	13
Ensuring impact of long‐acting HIV therapeutics through multi‐level treatment research: a view from NIH	13
High acceptability, feasibility and sustainability of a direct‐to‐pharmacy differentiated PrEP delivery model in public health HIV clinics in Kenya: perspectives of PrEP clients and healthcare provide	13
Examining barriers to antiretroviral therapy initiation in infants living with HIV in sub‐Saharan Africa despite the availability of point‐of‐care diagnostic testing: a narrative systematic review	13
Characterizing adolescent and youth‐friendly HIV services: a cross‐sectional assessment across 16 global sites	13
Improving ART initiation among men who use HIV self‐testing in Malawi: a qualitative study	12
Differences in clinical characteristics between adolescents and young adults with perinatally and sexually acquired HIV in the Asia‐Pacific region	12
AUTHOR INDEX	12
Reach, Acceptability, Feasibility and Impact of a Brief Community Health Worker‐Administered Index Case Testing Screening Tool “cICT” on Paediatric HIV Case Identification: Results From Malawi	12
An evaluation of nine culturally tailored interventions designed to enhance engagement in HIV care among transgender women of colour in the United States	12
Abstract Supplement Abstracts from IAS 2023, the 12th IAS Conference on HIV Science, 23 – 26 July, Brisbane, Australia & Virtual	12
The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub‐Saharan Africa: a scoping review	12
Aligning HIV treatment and hypertension clinic visits and dispensing as a first step towards service delivery integration in South Africa	12
Preferences for models of sexual health service delivery among gay, bisexual and other men who have sex with men in Australia: a discrete choice experiment	12
HIV pre‐exposure prophylaxis programme preferences among sexually active HIV‐negative transgender and gender diverse adults in the United States: a conjoint analysis	12
Occupational post‐exposure prophylaxis among healthcare workers: a scoping review of factors affecting optimal utilization	12
Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies	12
Person‐centred HIV prevention in an era of innovation and uncertainties	12
Being yourself is a defect: analysis of documented rights violations related to sexual orientation, gender identity and HIV in 2022 using the REAct system in six eastern European, Caucasus and Central	12
Providing HIV‐assisted partner services to partners of partners in western Kenya: an implementation science study	12
Awareness and intention to use event‐driven and long‐acting injectable pre‐exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross‐sectional	12
Prevalence and co‐occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low‐ and middle‐income countries: a cross‐sectional study	12
The ethics of exclusion: why pregnant and lactating women must be front and centre of HIV research	12
Non‐clinical considerations for supporting accelerated inclusion of pregnant women in pre‐licensure clinical trials with anti‐HIV agents	12
	12
	11
Bringing together the pieces: the need for holistic care for women with HIV	11
AUTHOR INDEX	11
Put rights at the centre of person‐ and people‐centred HIV prevention	11
Progress towards the elimination of vertical transmission of HIV, syphilis and hepatitis B in 21 high‐burden countries	11
Issue Information	11
Effectiveness and Persistence of Long‐Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort	11
Issue Information	11
Person‐centred, integrated non‐communicable disease and HIV decentralized drug distribution in Eswatini and South Africa: outcomes and challenges	11
	11
A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN‐035	11
AUTHOR INDEX	11
Failing to learn the lessons: the U.S. response on global health security ignores 20 years of PEPFAR	11
Long‐acting injectable ART to advance health equity: a descriptive analysis of US clinic perspectives on barriers, needed support and programme goals for implementation from applications to the ALAI U	10
The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study	10

Hidden in Plain Sight: HIV and LGBTQIA+ Realities in the Middle East and North Africa Region	10
PrEP awareness and protective barrier negotiation among transgender people attracted to men in Aotearoa New Zealand	10
	10
Projection of age of individuals living with HIV and time since ART initiation in 2030: estimates for France	10
Pre‐exposure prophylaxis in real life: experience from a prospective, observational and demonstration project among men who have sex with men in Benin, West Africa	10
Characteristics of individuals who received post‐exposure prophylaxis and HIV seroconversion in Malawi: an analysis of national routine HIV testing data	10
Scaling Up HIV Self‐Testing in Africa: Insights From National Programmatic Data in Eight Countries	10
Seizing the moment: the potential of PrEP choice and innovation to transform HIV prevention	10
Including transgender populations in mathematical models for HIV treatment and prevention: current barriers and policy implications	10
Knowledge as resistance: advancing global health in challenging times	10
Intentions and attitudes of caregivers towards enrolment of their children and adolescents living with HIV into remission trials involving analytic treatment interruption	10
	10
HIV prevention programme with young women who sell sex in Mombasa, Kenya: learnings for scale‐up	10
Programme science methodologies and practices that address “FURRIE” challenges: examples from the field	10
Untapped potential of post‐exposure prophylaxis in sub‐Saharan Africa: a comparative analysis of PEP implementation planning in Kenya, Mozambique, Nigeria, Uganda and Zambia	10
Population‐level effectiveness of pre‐exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data	10
Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review	10
Issue Information	10
What is not measured cannot be improved: the urgency to understand causes of HIV‐related deaths in Latin America	10
Treatment‐naïve people living with HIV aged 50 years or older in Beijing, China, 2010–2020: joinpoint regression model analysis of surveillance data	10
Examining the effect of universal testing and treatment strategies for HIV prevention in Zambia and South Africa: generalizing the results of the HPTN 071 (PopART) trial	10
Issue Information	10
“People have options”: a qualitative study of experiences and influences of PrEP choice among women in South Africa	10
The time is now to use the tools we have to end AIDS in children	10
Transforming PrEP marketing: understanding the place of PrEP in the hearts and minds of adolescent girls and young women in sub‐Saharan Africa	9
Comorbidities and HIV‐related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low‐ and middle‐income countries: a cross‐sectional study	9
A citizen science approach to develop a digital intervention to reduce HIV stigma and promote HIV self‐testing among adolescents and young adults: a mixed methods analysis from Kazakhstan	9
Adults with perinatally acquired HIV in low‐ and middle‐income settings: time for a generational shift in HIV care and global guidance	9
Issue Information	9
Issue Information	9
Recognizing and disrupting stigma in implementation of HIV prevention and care: a call to research and action	9
Emerging Dolutegravir Resistance Among Children on Antiretroviral Therapy With Virological Failure in Malawi: Results From a 2023 National Cross‐Sectional Survey	9
PrEP preferences and early acceptability of injectable cabotegravir among pregnant and lactating people in Cape Town, South Africa: findings from the PrEPared to Choose study	9
Non‐communicable disease (NCD) risk among people living with HIV in KwaZulu‐Natal, South Africa: evidence from a randomised trial of community‐based differentiated service delivery	9
New tricks for an old dog: opportunities for better tuberculosis control	9
Modelling the impact of CD4 testing on mortality from TB and cryptococcal meningitis among patients with advanced HIV disease in nine countries	9
High peak viraemia followed by spontaneous HIV‐1 control in women living with HIV‐1 subtype A1 in East Africa	9
Issue Information	9
Consequences of United States funding suspensions on community‐led HIV services in Latin America and the Caribbean: findings of a rapid service provider survey	9
AUTHOR INDEX	9
On the risk of using raw regional data on new HIV infections in France	9
Sustaining HIV service delivery to key population clients using client‐centered models during the debate and enactment of the Anti‐Homosexuality Act in Uganda	9
Iterative hypothesis testing in HIV vaccine research: moving towards success	8
	8
Beating the odds: medicines alone will not stop HIV	8
Hazardous alcohol use and HIV indicators in six African countries: results from the Population‐based HIV Impact Assessments, 2015–2017	8
	8
Excess mortality attributable to AIDS among people living with HIV in high‐income countries: a systematic review and meta‐analysis	8
Issue Information	8
Impact of the Anti‐Homosexuality Act on HIV service delivery in Uganda: Evidence from community‐led monitoring	8
Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey	8
A community‐based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial	8
Uganda's Anti‐Homosexuality Act undermines public health	8
Zero discrimination in practice: resisting anti‐trans backlash in the global HIV response	8
Correction to Evaluation of point‐of‐care diagnostics for sexually transmitted infection on oral PrEP initiation and persistence among young people in South Africa: a randomized controlled study	8
HIV in Gaza: From Chronic Under‐Detection to Acute Collapse	8
	8
AUTHOR INDEX	8
Predictors of PrEP awareness, PrEP discussion and interest in long‐acting injectable PrEP among Filipina transfeminine adults	8
How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub‐Saharan Africa: a mixed methods analysis	8
Retraction:	8
HIV awareness and prevention strategies among transgender women in the Eastern and Southern United States: findings from the LITE Study	8
	8
Correction to “What is not measured cannot be improved: the urgency to understand causes of HIV‐related deaths in Latin America”	8
Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study	8
	8
Very high HIV prevalence and incidence among men who have sex with men and transgender women in Indonesia: a retrospective observational cohort study in Bali and Jakarta, 2017–2020	8
Prevalence, correlates and solutions to people with HIV in China being refused treatment for diseases not related to HIV: a mixed‐methods study	8
Research priorities for advanced HIV disease in Latin America and the Caribbean region: a modified Delphi study	8
Community‐ and individual‐level correlates of HIV incidence in HPTN 071 (PopART)	8
Prevalence and risk factors of hypertension and diabetes among persons living with HIV in Zambia: results of a national facility‐based cross‐sectional survey	7
Person‐centred care: shifting the power dynamic in the delivery of adolescent and youth‐friendly health services	7
Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohorts	7
PrEP choice in the real world: Results of a prospective cohort study describing uptake and use patterns of oral PrEP and the dapivirine vaginal ring among women in sub‐Saharan Africa	7
Navigating grey areas in HIV and mental health implementation science	7
Estimating the potential value of MSM‐focused evidence‐based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model‐based analysis	7
The promise of a “cure” for HIV: implications for the future of PEPFAR‐supported HIV programmes	7
Left behind on the path to 90‐90‐90: understanding and responding to HIV among displaced people	7
The science at HIVR4P 2024: The era of choice in biomedical HIV prevention	7
Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection	7
No significant drug−drug interaction between oral TAF‐based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT‐3 study	7
A pretest‐posttest design to assess the effectiveness of an intervention to reduce HIV‐related stigma and discrimination in healthcare settings in Vietnam	7
“Will you need this health at all? Will you be alive?”: using the bioecological model of mass trauma to understand HIV care experiences during the war in Ukraine	7
Intervention strategies to improve adherence to treatment for selected chronic conditions in sub‐Saharan Africa: a systematic review	7
Persistent low‐level viraemia is associated with non‐infectious comorbidities in an observational cohort in four African countries	7
Characterizing HIV seroconversions among a cohort of oral PrEP users in South Africa	7
	7
Corrigendum	7
Temporal dynamics and drivers of durable HIV viral load suppression and persistent high‐ and low‐level viraemia during Universal Test and Treat scale‐up in Uganda: a population‐based study	7
The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa	7
The association between adherence to antiretroviral therapy and viral suppression under dolutegravir‐based regimens: an observational cohort study from Uganda	7
Rewriting the narrative: resilience of youth in the HIV response	7
Issue Information	7
Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locati	7
A modelling framework for translating discrete choice experiment results into cost‐effectiveness estimates: an application to designing tailored and scalable HIV and contraceptive services for adolesc	7